Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 92

Sort by

Sort Order Select

Journal Articles

A Pilot Study to Determine the Safety and Efficacy of Repeated Hyperbaric Oxygen Therapy in Multiple Myeloma Patients Undergoing High-Dose Therapy and Autologous Stem/Progenitor Cell Transplantation

Eric J Huselton, Howard Langstein, Jane L. Liesveld, Omar Aljitawi

Blood (2023) 142 (Supplement 1): 7068.

https://doi.org/10.1182/blood-2023-189851

Published: 2023

Journal Articles

Telehealth Serious Illness Care Program for Older Adults with Acute Myeloid Leukemia and Myelodysplastic Syndromes: A Single-Arm Pilot Study

Marissa Locastro, Soroush Mortaz-Hedjri, Ying Wang, Jason H. Mendler, Sally Norton, Rachelle Bernacki, Thomas Carroll, Heidi Klepin, Jane L. Liesveld, Eric J Huselton, Benzi Kluger, Kah Poh Loh

Blood (2023) 142 (Supplement 1): 260.

https://doi.org/10.1182/blood-2023-174563

Published: 2023

Journal Articles

Hyperbaric Oxygen (HBO) Effects on Blood Count Recovery and Post-Transplant Outcomes Following High-Dose Therapy and Autologous HSPC Transplantation for Multiple Myeloma: A Multicenter Phase II Randomized Clinical Trial

Leyla Shune, Ayman Qasrawi, Gerhard Hildebrandt, Eric J Huselton, Howard Langstein, Dennis Allin, Kaitlyn Burrows, Andrea M Baran, Jane L. Liesveld, Neil Blumberg, Brea Lipe, Andrew G Evans, Derick R Peterson, Omar Aljitawi

Blood (2023) 142 (Supplement 1): 2221.

https://doi.org/10.1182/blood-2023-190079

Published: 2023

Journal Articles

Long-Term Follow up for SWOG 1318: Combination of Dasatinib, Prednisone, and Blinatumomab for Older Patients with Philadelphia-Chromosome (Ph) Positive Acute Lymphoblastic Leukemia (ALL)

Anjali S. Advani, Anna B Moseley, Kristen M. O'Dwyer, Brent L. Wood, Jae H. Park, Matthew J. Wieduwilt, Deepa Jeyakumar, George Yaghmour, Ehab L. Atallah, Aaron T. Gerds, Susan M. O'Brien, Jane L. Liesveld, Megan Othus, Mark R. Litzow, Richard M Stone, Elad Sharon, Cecilia C.S. Yeung, Jerald P. Radich, Harry P. Erba

Blood (2023) 142 (Supplement 1): 1499.

https://doi.org/10.1182/blood-2023-180204

Published: 2023

Journal Articles

Safety and Efficacy of Outpatient Myeloablative Busulfan Conditioning in Allogeneic Stem Cell Transplantation

John Cliburn, Kara Kubli, Tate Feeney, Margaret Blaney, Victoria Zhang, Omar Aljitawi, Jane L. Liesveld, Michael W. Becker, Eric J Huselton

Blood (2023) 142 (Supplement 1): 2158.

https://doi.org/10.1182/blood-2023-188964

Published: 2023

Journal Articles

Patient Values, Information Preferences, and Decisional Preferences Among Older Adults with Acute Myeloid Leukemia

Kah Poh (Melissa) Loh, Soroush Mortaz-Hedjri, Ying Wang, Marissa Locastro, Sally Norton, Jason H. Mendler, Jane L. Liesveld, Eric J Huselton, Marielle Jensen-Battaglia, Kathryn Buettner, Jenae Davis, Heidi Klepin, Daniel R. Richardson

Blood (2023) 142 (Supplement 1): 2352.

https://doi.org/10.1182/blood-2023-172827

Published: 2023

Journal Articles

Isocitrate Dehydrogenase 2 Mutation Allows Myeloid Differentiation but Impairs Bone Marrow Macrophage Polarization and Function Via Metabolic Dysregulation

Noah A Salama, Emily R Quarato, Olivia Lynch, Yuko Kawano, Chen Yu, Benjamin Rodems, Eric Cefaloni, Marlies P. Rossmann, Paula Vertino, Laurie A. Steiner, Kathleen E. McGrath, James Palis, Roman Eliseev, Jane L. Liesveld, Jeevisha Bajaj, Laura Calvi

Blood (2023) 142 (Supplement 1): 314.

https://doi.org/10.1182/blood-2023-190617

Published: 2023

Journal Articles

Persistent Contamination By Bone and Bone Marrow-Derived Macrophages Obscures Functional Assessment of Tissue-Dependent Heterogeneity in Mesenchymal Stromal Cells

Yuko Kawano, Hiroki Kawano, Stephanie Busch, Allison Li, Jane Zhang, Noah A Salama, Emily R Quarato, Chunmo Chen, Mary Georger, Mitra Azadniv, Daniel Byun, Elizabeth A Lamere, Mark W Lamere, Jane L. Liesveld, Michael W. Becker, Laura Calvi

Blood (2023) 142 (Supplement 1): 5623.

https://doi.org/10.1182/blood-2023-191175

Published: 2023

Journal Articles

A Patient-Centered Communication Tool for Older Patients with Acute Myeloid Leukemia, Their Caregivers, and Oncologists: A Single Arm Pilot Study

Marissa Locastro, Chandrika Sanapala, Ying Wang, Marielle Jensen-Battaglia, Marsha Wittink, Sally Norton, Heidi Klepin, Daniel R. Richardson, Jason H. Mendler, Jane L. Liesveld, Eric J. Huselton, Kristen M. O'Dwyer, Ashley-Marie Cortes, Chrystina Rodriguez, Kah Poh (melissa) Loh

Blood (2022) 140 (Supplement 1): 324–325.

https://doi.org/10.1182/blood-2022-165499

Published: 2022

Journal Articles

Association of Crystalloid Fluid Infusion with Altered Red Blood Cell (RBC) Morphology, Intravascular Hemolysis, and Organ Dysfunction in Hematopoietic Stem Cell Transplant Patients

Melissa R. Holloway, Neil Blumberg, Eric J. Huselton, Kristen M. O'Dwyer, Jane L. Liesveld, Jeffrey R. Andolina, Kelly Henrichs, Thomas J. Fountaine

Blood (2022) 140 (Supplement 1): 11383.

https://doi.org/10.1182/blood-2022-156368

Published: 2022

Journal Articles

Isocitrate Dehydrogenase 2 Mutation Drives Bone Marrow Macrophage Dysfunction without a Complete Block in Hematopoietic Differentiation

Noah Salama, Olivia Lynch, Emily R Quarato, Yuko Kawano, Benjamin Rodems, Eric Cefaloni, Tzu-Chieh Ho, Kathleen E. McGrath, Michael W. Becker, Jane L. Liesveld, Paula M Vertino, James Palis, Jeevisha Bajaj, Laura M. Calvi

Blood (2022) 140 (Supplement 1): 9757–9758.

https://doi.org/10.1182/blood-2022-168015

Published: 2022

Journal Articles

Therapeutic Modulation of the Marrow Microenvironment in MDS: A Phase I Trial of Abaloparatide and Bevacizumab

Jozal W. Moore, Jason H. Mendler, Kah Poh (melissa) Loh, Mitra Azadniv, Kristen M. O'Dwyer, Eric J. Huselton, Frank Akwaa, Benjamin J. Frisch, Myla Strawderman, Mark W. LaMere, Daniel K. Byun, Alyssa C. Jasper, Michael W. Becker, Jane L. Liesveld, Laura M. Calvi

Blood (2022) 140 (Supplement 1): 4050–4052.

https://doi.org/10.1182/blood-2022-159515

Published: 2022

Journal Articles

Human NGFR+/VCAM-1+/Mcam+ Bone Marrow-Derived Stromal Cells (NVML) Provide Enhanced Support for Normal Hematopoiesis and Are Disrupted in Myelodysplastic Syndrome

Yuko Kawano, Hiroki Kawano, Daniel K. Byun, Dalia Ghoneim, Thomas J Fountaine, Mark W. LaMere, John M. Ashton, Mitra Azadniv, Jane L. Liesveld, Youmna Kfoury, David T. Scadden, Michael W. Becker, Laura M. Calvi

Blood (2022) 140 (Supplement 1): 5772–5773.

https://doi.org/10.1182/blood-2022-170070

Published: 2022

Journal Articles

Adaptation of the Serious Illness Care Program for Older Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes

Marissa Locastro, Chandrika Sanapala, Jason H. Mendler, Sally Norton, Rachelle Bernacki, Thomas Carroll, Heidi Klepin, Erin Watson, Jane L. Liesveld, Eric J. Huselton, Kristen M. O'Dwyer, Andrea M Baran, Marie Flannery, Benzi Kluger, Kah Poh (melissa) Loh

Blood (2022) 140 (Supplement 1): 10839–10840.

https://doi.org/10.1182/blood-2022-165583

Published: 2022

Journal Articles

Phase 1/2 study of uproleselan added to chemotherapy in patients with relapsed or refractory acute myeloid leukemia

Daniel J. DeAngelo, Brian A. Jonas, Jane L. Liesveld, Dale L. Bixby, Anjali S. Advani, Paula Marlton, John L. Magnani, Helen M. Thackray, Eric J. Feldman, Michael E. O’Dwyer, Pamela S. Becker

Blood (2022) 139 (8): 1135–1146.

https://doi.org/10.1182/blood.2021010721

Published: 2022

Includes: Supplemental data

Journal Articles

A Phase 2 Study of Dasatinib, Prednisone, and Blinatumomab for Older Patients with Philadelphia-Chromosome (Ph) Positive or Ph-like Acute Lymphoblastic Leukemia (ALL) (with Dasatinib Sensitive Fusions/ Mutations)

Anjali Advani, Anna Moseley, Kristen O'Dwyer, Brent Wood, Jae H Park, Matthew Wieduwilt, Deepa Jeyakumar, George Yaghmour, Ehab L. Atallah, Aaron T. Gerds, Susan M. O'Brien, Jane L. Liesveld, Megan Othus, Mark R. Litzow, Richard M. Stone, Elad Sharon, Harry P. Erba

Blood (2021) 138 (Supplement 1): 3397.

https://doi.org/10.1182/blood-2021-145529

Published: 2021

Journal Articles

Interleukin-1/Toll-like Receptor Inhibition Can Restore the Disrupted Bone Marrow Microenvironment in Mouse Model of Myelodysplastic Syndromes

Hiroki Kawano, Yuko Kawano, Mark W. LaMere, Daniel K. Byun, Caitlin L. Gordnier, Elizabeth A. LaMere, Tzu-Chieh Ho, John M. Ashton, Benjamin J. Frisch, Jeevisha Bajaj, Jane L. Liesveld, Laura M. Calvi, Michael W. Becker

Blood (2021) 138 (Supplement 1): 1510.

https://doi.org/10.1182/blood-2021-152885

Published: 2021

Journal Articles

SY-1425, a Potent and Selective RARα Agonist, in Combination with Azacitidine Demonstrates a High Complete Response Rate and a Rapid Onset of Response in RARA-Positive Newly Diagnosed Unfit Acute Myeloid Leukemia

Stephane De Botton, Thomas Cluzeau, MDPhD, Carlos Enrique Vigil, MD, Rachel J. Cook, MD, Philippe Rousselot, MDPhD, David A Rizzieri, MD, Jane L. Liesveld, MD, Pierre Fenaux, MD PhD, Thorsten Braun, MD PhD, Anne Banos, MD, Michael R. Savona, MD, Don Park, MD, Michael J. Kelly, MD MPH, MS, Angela Volkert, Li Zhou, PhD, Qing Kang-Fortner, PhD, David A. Roth, MD, Eytan M. Stein, MD

Blood (2020) 136 (Supplement 1): 4–5.

https://doi.org/10.1182/blood-2020-134600

Published: 2020

Journal Articles

Initial Results from a Biomarker-Directed Phase 2 Trial of SY-1425, a Potent and Selective RARα Agonist, in Combination with Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia

Eytan M. Stein, MD, Stephane De Botton, Thomas Cluzeau, MDPhD, Arnaud Pigneux, MD PhD, Jane L. Liesveld, MD, Rachel J. Cook, MD, Philippe Rousselot, MDPhD, David A Rizzieri, MD, Thorsten Braun, MD PhD, Dale L. Bixby, MD, Gail J. Roboz, MD, Delphine Lebon, MD, Mael Heiblig, Michael J. Kelly, MD MPH, MS, Angela Volkert, Li Zhou, PhD, Qing Kang-Fortner, PhD, David A. Roth, MD, Pierre Peterlin, MD

Blood (2020) 136 (Supplement 1): 6–7.

https://doi.org/10.1182/blood-2020-134602

Published: 2020

Journal Articles

Early Completion of Medical Orders for Life-Sustaining Treatment (MOLST) and Hospice Enrollment Are Associated with Improved End of Life (EOL) Quality Metrics in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS)

Marissa Locastro, BS, Kah Poh Loh, MBBCHBAO, Andrea M. Baran, MS, Jane L. Liesveld, MD, Michael W. Becker, MD, Kristen Marie O'Dwyer, MD, Eric Huselton, MD, Omar S. Aljitawi, MD, Megan Baumgart, MD, Eric Snyder, Benzi Kluger, MD, Jason H. Mendler, MD PhD

Blood (2020) 136 (Supplement 1): 20–21.

https://doi.org/10.1182/blood-2020-139475

Published: 2020

NARROW

A Pilot Study to Determine the Safety and Efficacy of Repeated Hyperbaric Oxygen Therapy in Multiple Myeloma Patients Undergoing High-Dose Therapy and Autologous Stem/Progenitor Cell Transplantation

Telehealth Serious Illness Care Program for Older Adults with Acute Myeloid Leukemia and Myelodysplastic Syndromes: A Single-Arm Pilot Study

Hyperbaric Oxygen (HBO) Effects on Blood Count Recovery and Post-Transplant Outcomes Following High-Dose Therapy and Autologous HSPC Transplantation for Multiple Myeloma: A Multicenter Phase II Randomized Clinical Trial

Long-Term Follow up for SWOG 1318: Combination of Dasatinib, Prednisone, and Blinatumomab for Older Patients with Philadelphia-Chromosome (Ph) Positive Acute Lymphoblastic Leukemia (ALL)

Safety and Efficacy of Outpatient Myeloablative Busulfan Conditioning in Allogeneic Stem Cell Transplantation

Patient Values, Information Preferences, and Decisional Preferences Among Older Adults with Acute Myeloid Leukemia

Isocitrate Dehydrogenase 2 Mutation Allows Myeloid Differentiation but Impairs Bone Marrow Macrophage Polarization and Function Via Metabolic Dysregulation

Persistent Contamination By Bone and Bone Marrow-Derived Macrophages Obscures Functional Assessment of Tissue-Dependent Heterogeneity in Mesenchymal Stromal Cells

A Patient-Centered Communication Tool for Older Patients with Acute Myeloid Leukemia, Their Caregivers, and Oncologists: A Single Arm Pilot Study

Association of Crystalloid Fluid Infusion with Altered Red Blood Cell (RBC) Morphology, Intravascular Hemolysis, and Organ Dysfunction in Hematopoietic Stem Cell Transplant Patients

Isocitrate Dehydrogenase 2 Mutation Drives Bone Marrow Macrophage Dysfunction without a Complete Block in Hematopoietic Differentiation

Therapeutic Modulation of the Marrow Microenvironment in MDS: A Phase I Trial of Abaloparatide and Bevacizumab

Human NGFR+/VCAM-1+/Mcam+ Bone Marrow-Derived Stromal Cells (NVML) Provide Enhanced Support for Normal Hematopoiesis and Are Disrupted in Myelodysplastic Syndrome

Adaptation of the Serious Illness Care Program for Older Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes

Phase 1/2 study of uproleselan added to chemotherapy in patients with relapsed or refractory acute myeloid leukemia

A Phase 2 Study of Dasatinib, Prednisone, and Blinatumomab for Older Patients with Philadelphia-Chromosome (Ph) Positive or Ph-like Acute Lymphoblastic Leukemia (ALL) (with Dasatinib Sensitive Fusions/ Mutations)

Interleukin-1/Toll-like Receptor Inhibition Can Restore the Disrupted Bone Marrow Microenvironment in Mouse Model of Myelodysplastic Syndromes

SY-1425, a Potent and Selective RARα Agonist, in Combination with Azacitidine Demonstrates a High Complete Response Rate and a Rapid Onset of Response in RARA-Positive Newly Diagnosed Unfit Acute Myeloid Leukemia

Initial Results from a Biomarker-Directed Phase 2 Trial of SY-1425, a Potent and Selective RARα Agonist, in Combination with Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia

Early Completion of Medical Orders for Life-Sustaining Treatment (MOLST) and Hospice Enrollment Are Associated with Improved End of Life (EOL) Quality Metrics in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only